Incidence and associated factors of cetuximab-induced hypersensitivity infusion reactions in 1392 cancer patients treated in four French areas: a possible association with Lyme disease?
Dupont M, Carlier C, Gower-Rousseau C, Barbier-Lider P, Botsen D, Brasseur M, Burgevin A, Chourbagi C, D'Almeida R, Hautefeuille V, Hentzien M, Lambert A, Lamuraglia M, Lavau-Denes S, Lopez A, Parent D, Slimano F, Brugel M, Bouché O.
Dupont M, et al. Among authors: slimano f.
BMC Cancer. 2022 Nov 25;22(1):1219. doi: 10.1186/s12885-022-10192-4.
BMC Cancer. 2022.
PMID: 36434607
Free PMC article.